Search results for: 'value based procurement'

The data center industry can achieve decarbonization of Scope 1 and 2 emissions through two big approaches: renewable energy procurement and efficiency measures. On the renewables side, power purchase agreements (PPAs) within a local electricity market are currently the most effective way for the data center industry to fund and procure renewab...

Frost & Sullivan has recently completed a comprehensive analysis on the current and future strategic imperatives of game-changing Asia-Pacific (APAC) pharmaceutical companies. The analysis primarily focuses on the changing trends in the pharmaceutical industry with respect to drug research and development, manufacturing, supply chain, and marketing...

22 Jan 2021  |  South Asia, Middle East & North Africa  |  Market Research

Sustainability and Digital Transformation Boost FM Uptake in GCC Countries

The Shift from Price to Value-based Bundled Contracts Drive Growth Opportunities

Infographics

×

Key Issues Addressed

Facility management (FM) is gaining traction in the GCC, as more end users have begun to appreciate the impact FM has on the bottom line; energy management is now being incorporated into FM Contracts. Besides, the use of sophisticated assets means that they will require higher quality and standards of asset management. With mega events, such as...

27 Jan 2021  |  North America  |  Market Research

Advanced Technologies that Enhance Integrated Workflow, Productivity, Patient Safety, and Detection Capabilities Drive the Global Digital Radiography Market

Technology Strategies Shift among Manufacturers with the Emergence of Value-based Imaging

Infographics

×

Key Issues Addressed

This study presents an analysis of the global digital radiography (DR) market. It provides an in-depth breakdown of current trends, market size, revenue forecast, market penetration, and market attractiveness in 3 segments: turnkey suites, mobile DR, and DR retrofits. Regional Coverage: North America: United States and Canada; Europe: Western Euro...

The geospatial value-added services market is seeing an influx of new participants owing to cheaper satellite data products and services and enabling information and communication technologies. Established incumbents have to compete with not only these participants but also new customer groups arising from the evolution of new use cases. The marke...

The automotive industry is experiencing a significant transformation, transitioning from conventional to software-defined vehicles. As vehicles develop into intelligent, connected platforms driven by electrification, autonomous driving technologies, and digital services, traditional original equipment manufacturers (OEMs) are confronted with increa...

04 Sep 2018  |  North America  |  Market Research

Digital Transformation in the Pharmaceuticals Industry—Companies-to-Action, 2018

Value-based Care, Patient Data Digitization, and Collaborative Technology Deployment Offer Investment Opportunities

Infographics

×

Key Issues Addressed

The pharmaceutical industry today is in a state of flux as it tries to maintain a delicate balance between the need for novel blockbuster drugs and the need for improved operational efficiencies in an increasingly competitive market space. As healthcare is becoming increasingly democratized, patients are emerging as key decision makers—digitally en...

12 Aug 2020  |  North America  |  Market Research

Strategic Commercial Partnerships Transforming the Global Biobanking Market, 2020–2026

Precision Medicine Applications and Value-based Data Pricing with Pharma and Health-tech to Trigger Market Growth

Infographics

×

The biobanking ecosystem is witnessing significant transformation. Emergence of one-stop shops and virtual biobanks, rise in services offered to sustain and improve positioning, and precision medicine are characterizing this transformative environment. The biobanking market is expected to reach a size of ~$71.2 billion by 2026, registering a compou...

he global life science industry is in a state of flux. While the recent years have seen the advent of multiple novel technologies, such as in-vitro diagnostics (IVD), CRISPR-Cas9, virtual clinical trials, and liquid biopsy, the industry stands at a crossroad with challenges in scaling-up and commercializing such technologies. In addition, companies...